A plaintiff from Kentucky has filed a lawsuit against the drug maker Takeda for enduring bladder cancer due to Actos. The lawsuit was filed on December 13, 2012 in the Circuit Court of Cook County, Illinois. According to the reports, the plaintiff was named as Philip Viniard, a resident of Kentucky. According to the Actos Bladder cancer Lawsuit filed by the plaintiff and his Actos attorney, he began taking the diabetes controlling drug after being advised by his doctor. However in 2007 he was diagnosed with bladder cancer, a kind of Cancer that proved to be detrimental for his health and well-being.

According to the lawsuit, the plaintiff and his

Actos lawsuit attorney

have brought in a number of counts against the manufacturer including product liability, negligence, concealing of relevant information and breach of warranties. In the lawsuit the plaintiff has also claimed that he was unaware of the fact that his bladder cancer diagnosis could be linked to Actos until June 2011 when a warning was issued by the FDA.

About Actos

Actos is a prescription drug that was approved by the federal agency United States Food and Drug Administration in the year of 1999 and since then it has been widely prescribed by doctors and healthcare professionals across United States to treat the condition of Type II Diabetes. Actos is basically a Pioglitazone that is sold as single-ingredient product under the brand-name Actos to regulate the amount of glucose in adults.

Side Effects of Actos

The most common side effects that can be experienced using the use of actos are:

  • Upper respiratory tract infection
  • Headaches
  • Sinusitis
  • Muscle pain
  • Tooth disorders
  • Soring throat
  • Swelling of ankles
  • Weight gain
  • Fluid retention and accumulation in body

Some Basic Facts about Actos:

  • The prescription drug Actos is manufactured and marketed by Takeda Pharma one of the drug maker based at North America
  • Reports from federal agency FDA it is estimated that from January 2010 through October 2010, approximately 2.3 million patients filled a prescription for a pioglitazone-containing product.
  • Actos is also sold in combination with metformin and glimepiride
  • The prescription tablet is used along with diet and exercise to regulate the level of blood sugar in adults with type 2 diabetes mellitus.

Various warning letter was issued to Takeda Pharmaceuticals over the diabetic drug Actos that were based on various studies that examined and analyzed millions of patients. According to these reports, patients who used Actos for a prolonged period of 12 months or more had a 40 percent increased risk of developing Bladder Cancer.